When Israeli chemist Raphael Mechoulam discovered CBD in the 1960s, it should have been a big deal, but it wasn’t.
When he published the results of clinical tests in the 1980s showing that CBD was beneficial for epileptic patients, it should have been a big deal, but it wasn’t. More than 40 years later, CBD is finally gaining mainstream acceptance as a health and wellness product.
Mechoulam has been pushing cannabis science forward with virtually no recognition ever since. He’s doing it again.
Recently, he and a group of scientists announced that they believe they’ve found a way to synthesize cannabis acids, chemicals that are found in the cannabis plant when it is alive (as opposed to dried). And the resulting compound could be stronger and more medically beneficial than current formulations of THC and CBD.
For instance, CBDA – the acid form of CBD – is thought to be a thousand times more potent than CBD when acting on the serotonin receptors in the brain that are responsible for CBD’s calming effect.
Mechoulam told NBC news recently that he hopes this discovery doesn’t take decades to catch on like CBD.
“We could have helped a lot of children with cannabidiol for many years,” he says. “I hope this doesn’t happen with the new compound.”